stockrow
Friday 6 November 2026
Export KIDS’s income statement to Excel — free account
OrthoPediatrics Corp.
KIDS Healthcare Medical Devices
OrthoPediatrics Corp.’s revenue for fiscal 2025 (year ended December 2025) was $236.3 million, up 15.4% from fiscal 2024.
- Revenue
- +18.6%
- EPS
- +50.9%
- Free cash flow
- +146.6%
- Total debt
- +0.99%
Quarter to September 2026, against a year earlier
31.69
0.53
−1.64%
Follow KIDS
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
1.76 | 1.54 | 1.82 | 2.04 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 500.85 | |
P/Operating CF |
40.26 | (114.35) | 495.75 | 119.38 | |
P/B ratio |
1.20 | 1.11 | 1.34 | 1.59 | |
Price to Tangible BV |
2.61 | 2.56 | 3.10 | 3.66 | |
EV/Sales |
1.91 | 1.74 | 2.02 | 2.24 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 729.40 | |
EV/Operating CF |
(92.94) | (106.07) | 68.81 | 47.28 | |
EV/FCF |
(24.95) | (28.67) | (129.34) | 550.11 | |
Quick Ratio |
2.53 | 2.23 | 2.06 | 1.88 | |
Current Ratio |
5.55 | 5.21 | 4.78 | 4.55 | |
Net Debt/EBITDA |
(154.81) | (17.79) | 30.33 | 26.36 | |
Debt/Assets |
19.10% | 19.39% | 19.09% | 19.22% | |
Debt/Equity |
0.28 | 0.29 | 0.28 | 0.29 | |
Asset Turnover |
0.48 | 0.50 | 0.50 | 0.53 | |
Operating CF/Net income |
(1.02) | 0.31 | (0.13) | (0.76) | |
Capex/Depreciation |
(0.08) | (0.31) | (0.71) | (0.47) | |
Interest Coverage |
(4.23) | (3.97) | (1.61) | (1.61) | |
Research and Development Expense of Revenue |
3.67% | 3.76% | 3.30% | 3.39% | |
Selling, General and Administrative Expense of Revenue |
78.49% | 83.38% | 76.74% | 75.87% | |
Intangible Assets out of Total Assets |
0.37 | 0.38 | 0.38 | 0.38 | |
Share Based Compensation of Revenue |
7.17% | 6.71% | 5.94% | 6.08% | |
Graham Net Nets |
0.23 | 0.22 | 0.18 | 0.16 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(9.52%) | (10.59%) | (8.78%) | (6.40%) | |
Free Cash Flow Yield |
(4.34%) | (3.92%) | (0.86%) | 0.20% | |
Revenue per Share |
2.63 | 2.51 | 2.93 | 3.01 | |
Operating CF per Share |
0.44 | (0.14) | 0.04 | 0.19 | |
Capex per Share |
(0.03) | (0.07) | (0.17) | (0.12) | |
Free Cash Flow per Share |
0.42 | (0.21) | (0.13) | 0.07 | |
Cash per Share |
2.68 | 2.15 | 1.99 | 1.86 | |
Shareholders Equity per Share |
14.77 | 14.30 | 14.29 | 14.05 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
14.77 | 14.30 | 14.29 | 14.05 | |
Free Cash Flow |
9.75 | (5.05) | (3.12) | 1.60 | |
Working Capital |
210.22 | 198.68 | 199.66 | 197.61 | |
Capital Expenditures |
(0.60) | (1.76) | (4.04) | (2.91) | |
Net Current Asset Value |
94.39 | 82.39 | 84.73 | 83.50 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.01 | 0.03 | 0.06 | 0.04 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
48.10 | 49.21 | 57.37 | 55.41 | |
Average Payables |
13.85 | 16.95 | 17.46 | 15.82 | |
Average Inventory |
125.40 | 126.89 | 131.42 | 135.34 | |
Average Assets |
490.92 | 486.22 | 507.50 | 501.29 | |
Average Common Equity |
350.58 | 342.93 | 349.56 | 344.33 |
Columns are period end dates · fundamentals updated 2 Nov 2026